pharmaceutical Logos and Brands
Individual pharmaceutical companies and their visual identities are discussed in the “Pharmaceutical” section. AstraZeneca, with the Oxford COVID-19 vaccine; Eli Lilly, with breakthrough GLP-1 drugs for obesity (Mounjaro); Sanofi; Bayer; and GSK (GlaxoSmithKline) are corporations whose R&D budgets are in the billions. Mergers and acquisitions (Pfizer and Seagen for $43 billion, AbbVie and Allergan for $63 billion) are constantly redrawing the industry map and logos on the facades of headquarters. This section captures the visual transformations of companies whose drugs are prescribed by doctors and whose brands are read by hundreds of millions of patients on packaging.
